Metabolites
Displaying compounds 1726 - 1750 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB13436 | PA(10:0/16:1(11Z)) | [(2R)-3-(decanoyloxy)-2-[(11Z)-hexadec-11-enoyloxy]propoxy]phosphonic acid | C29H55O8P 562.725 | |
| YMDB00460 | 3-Hexaprenyl-4,5-dihydroxybenzoic acid 63975-40-6 | 3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-4,5-dihydroxybenzoic acid | C37H54O4 562.8223 | |
| YMDB16275 | UDP-4-Deoxy-4-formamido-beta-L-arabinose | N-[(3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-4,5-dihydroxyoxan-3-yl]carboximidic acid | C15H23N3O16P2 563.3011 | |
| YMDB01649 | Castavinol C1 | 1-[(1S,9S,12R)-5-hydroxy-9-(4-hydroxy-3,5-dimethoxyphenyl)-11-methyl-12-{[(2S,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8,10-dioxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-11-yl]ethan-1-one | C27H32O13 564.5352 | |
| YMDB01652 | Castavinol C4 | 1-[(1R,9R,12S)-5-hydroxy-9-(4-hydroxy-3,5-dimethoxyphenyl)-11-methyl-12-{[(2S,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8,10-dioxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-trien-11-yl]ethan-1-one | C27H32O13 564.5352 | |
| YMDB13418 | PA(12:0/14:0) | [(2R)-3-(dodecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphonic acid | C29H57O8P 564.7318 | |
| YMDB13416 | PA(10:0/16:0) | [(2R)-3-(decanoyloxy)-2-(hexadecanoyloxy)propoxy]phosphonic acid | C29H57O8P 564.741 | |
| YMDB00342 | 2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol | 3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-methoxy-2-methylcyclohexa-2,5-diene-1,4-diol | C38H60O3 564.8812 | |
| YMDB01130 | DG(16:1(9Z)/16:1(9Z)/0:0) | (2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (9Z)-hexadec-9-enoate | C35H64O5 564.892 | |
| YMDB12944 | DG(16:1(11Z)/16:1(11Z)/0:0) | (2R)-1-[(11Z)-hexadec-11-enoyloxy]-3-hydroxypropan-2-yl (11Z)-hexadec-11-enoate | C35H64O5 564.892 | |
| YMDB12945 | DG(16:1(11Z)/16:1(9Z)/0:0) | (2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropyl (11Z)-hexadec-11-enoate | C35H64O5 564.892 | |
| YMDB12974 | DG(16:1(9Z)/16:1(11Z)/0:0) | (2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (11Z)-hexadec-11-enoate | C35H64O5 564.892 | |
| YMDB12772 | DG(14:1(11Z)/18:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl (11Z)-octadec-11-enoate | C35H64O5 564.892 | |
| YMDB12773 | DG(14:1(11Z)/18:1(9Z)/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl (9Z)-octadec-9-enoate | C35H64O5 564.892 | |
| YMDB12798 | DG(14:1(9Z)/18:1(11Z)/0:0) | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (11Z)-octadec-11-enoate | C35H64O5 564.892 | |
| YMDB12799 | DG(14:1(9Z)/18:1(9Z)/0:0) | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (9Z)-octadec-9-enoate | C35H64O5 564.892 | |
| YMDB13563 | PC(10:0/10:0) | (2-{[(2R)-2,3-bis(decanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium | C28H56NO8P 565.729 | |
| YMDB13853 | PE-NMe(10:0/12:0) | [3-(decanoyloxy)-2-(dodecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C28H56NO8P 565.729 | |
| YMDB16182 | Ceramide (d18:1/18:0) | N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]octadecanamide | C36H71NO3 565.9538 | |
| YMDB00415 | UDP-D-glucose 133-89-1 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | C15H24N2O17P2 566.3018 | |
| YMDB00692 | UDP-D-galactose 2956-16-3 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | C15H24N2O17P2 566.3018 | |
| YMDB00212 | Uridine diphosphate glucose 133-89-1 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | C15H24N2O17P2 566.3018 | |
| YMDB00797 | udp-galactose 2956-16-3 | [({[(2R,3S,4R,5S)-5-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | C15H24N2O17P2 566.3018 | |
| YMDB01128 | DG(16:0/16:1(9Z)/0:0) | (2R)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (9Z)-hexadec-9-enoate | C35H66O5 566.908 | |
| YMDB12916 | DG(16:0/16:1(11Z)/0:0) | (2R)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (11Z)-hexadec-11-enoate | C35H66O5 566.908 |